Recent News
Tuning Made Easy: NeuroLux Launches the Autotuner
NeuroLux has launched the Autotuner, an upgrade to the manual Antenna Tuner Box which matches the impedance of the source and the antenna. This step is crucial to the overall performance of the NeuroLux system, with accurate tuning corresponding to maximized power transfer to the implantable devices in any antenna configuration, and lab environment. However, […]
read more »
NeuroLux to Attend the 2019 Materials Research Society Spring Meeting and Exhibit
Come out to Phoenix, Arizona to attend the 2019 Materials Research Society Spring Meeting and Exhibit, where interdisciplinary researchers worldwide come to network and exchange knowledge. There will be seven different symposium sessions, ranging from topics on colloidal nanoparticles to In Situ experimentation and techniques. Join our CEO, Tony Banks, in symposium session EP02 on […]
read more »
NeuroLux Illuminate Workshop Has Arrived in China
NeuroLux is extending its reach to China as the global provider of breakthrough technologies for optogenetics. Its first international workshop invites the neuroscience community across China to see the system first hand and to interact with researchers behind the technology. Following the event, NeuroLux will start offering the technology in the country to encourage adoption […]
read more »
NeuroLux Hosts Its First Training Workshop
NeuroLux hosted its first training workshop on April 25-26, 2018 at Washington University School of Medicine in St. Louis, Missouri. The NeuroLux Illuminate Workshop 2018 provided attendees the opportunity to become trained on the technology and the surgical procedures, to listen to and interact with guest researchers who have active programs built around the Neurolux technology, […]
read more »
NeuroLux Illuminate 2018: Free technology and surgery training for neuroscientists!
NeuroLux offers the only wireless optogenetics device platform that is fully-implantable, ultralightweight, and battery-free. These systems dramatically improve and simplify the means for light delivery and control in optogenetics experiments, thereby catalyzing the further adoption of these methodologies by the neuroscience community. This workshop will provide attendees the opportunity to become trained on the technology […]
read more »Latest Development of an Upcoming Addition to Our Product Portfolio Published in PNAS!
Wireless optogenetics technology for neuroscience research has assisted the neuroscience community in controlling neural activation and silencing and catalyzed a desire for powerful synergistic tools. One of the latest advancement in complementary toolsets is the creation of fiber photometry, with capability to optically record neural activity. The currently-available tethered approach imposes physical constraints that restrict […]
read more »NeuroLux awarded NIH STTR Phase I Grant
NeuroLux, an early stage biotech company based in Champaign, IL, has been awarded a Small Business Technology Transfer (STTR) Phase I grant by the National Institutes of Health (NIH) to develop wireless, battery-free devices for programmable fluid delivery and optogenetic stimulation, in designs fully compatible with the existing NeuroLux HF wireless electronic platform and control […]
read more »
NeuroLux Spinal Optogenetics System Published in PAIN!
This new wireless platform that adapts near-field communication (NFC) technology and microscale LED technologies for optogenetic studies beyond the brain. The reported devices are designed specifically for implantation in a minimally invasive fashion over the mouse spinal cord for wireless and battery-free optogenetic interrogation of spinal circuits in freely moving animals. The studies utilized NeuroLux […]
read more »
Anthony Banks is Guest Speaker at University of Illinois Office of Technology Management’s Share the Vision 2017
Anthony Banks, one of the co-founders and the vice president of NeuroLux, Inc., will deliver a talk on innovative discovery tools for medical research as one of the guest speakers for Share the Vision 2017 on September 21, 2017, at the EnterpriseWorks Startup Incubator. The event is a startup showcase hosted by the Office of […]
read more »
NeuroLux Awarded Direct to Phase II Grant from the National Institutes of Health
NeuroLux is proud to announce that it has been awarded a Direct-to-Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Mental Health (NIMH) of the National Institutes of Health (NIH). The fund, totaling over $1.5M for two years, will support the development of next-generation devices that build on their existing commercial […]
read more »